Revised SPC: Xospata (gilteritinib) tablets

Update states that gilteritinib is an inhibitor of P-gp and BCRP in vitro, and therefore, caution is advised during co-administration with substrates of P-gp (e.g., digoxin, dabigatran) and BCRP (e.g., methotrexate, rosuvastatin).

Source:

electronic Medicines compendium